Blazing Star Merger Sub completes Walgreens debt tender offer
George Ng, the Chief Executive Officer of Processa Pharmaceuticals , Inc. (NASDAQ:PCSA), has recently acquired 87,200 shares of the company’s common stock. According to InvestingPro data, this purchase comes as the stock’s RSI indicates oversold territory, with shares trading at $0.59, down significantly from their 52-week high of $3.31. The shares were purchased at a price of $0.7975 each, amounting to a total investment of $69,542. Following this transaction, Ng holds 87,200 shares directly. This move reflects Ng’s continued confidence in the company’s prospects as he increases his stake in the pharmaceutical firm. While the company currently shows a weak financial health score, InvestingPro analysis suggests the stock is trading below its Fair Value, with 14 additional key insights available to subscribers.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.